Kelly Blackburn
Förmögenhet: 40 612 $ per 2026-09-30
Förmögenhet: 40 612 $ per 2026-09-30
Kelly Blackburn currently works at Bach Pharma, Inc., as Chief Executive Officer & Director from 2016 and CervoMed, Inc., as Executive Vice President-Clinical Development from 2025.
Ms. Blackburn also formerly worked at Millennium Pharmaceuticals, Inc., as Director-Clinical & Safety Operations from 2002 to 2006, aTyr Pharma, Inc., as Vice President-Clinical Affairs from 2013 to 2016, Vertex Pharmaceuticals, Inc., as Vice President-Clinical Development Operations from 2006 to 2012, and EIP Pharma, Inc., as Senior Vice President-Clinical Development from 2018 to 2023.
Ms. Blackburn received her undergraduate degree from the University of New Hampshire, graduate degree from Quinnipiac College, Inc., and graduate degree from Cambridge College Lima SRL.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CERVOMED INC. 0,09 % | 2026-10-22 | 13 674 ( 0,09 % ) | 40 612 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| CERVOMED INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-08-16 |
Bach Pharma, Inc.
Bach Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Verkställande Direktör | 2016-07-15 |
| Företag | Position | Slut |
|---|---|---|
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Företagsledare/Principal | 2023-08-01 |
| ATYR PHARMA, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2016-07-01 |
| VERTEX PHARMACEUTICALS INCORPORATED | Företagsledare/Principal | 2012-09-01 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Företagsledare/Principal | 2006-08-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Bach Pharma, Inc.
Bach Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quinnipiac College, Inc.
Quinnipiac College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge College Lima SRL
Cambridge College Lima SRL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Health Technology |
CervoMed, Inc.
CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån